Graviton Bioscience, a privately held clinical-stage biotechnology company focused on therapies that inhibit Rho/Rho-associated coiled-coil containing protein kinase 2 (ROCK2), along with other therapeutic compounds. 

Biotechnology

Life Sciences

Therapeutics

Graviton Bioscience

Graviton Bioscience's headquarters in New York, United States

Samuel Waksal

Alexandra Zanin-Zhorov

Amy Melsaether

Rui Wu

Suacer M. Tejeda

Christie Matsui

Julia Balanova

The Leadership Team at Graviton Bioscience is responsible for setting strategic direction, overseeing clinical and regulatory strategies, ensuring compliance and quality in clinical operations, and driving innovation in research and development. The team collaborates to effectively manage corporate strategy, communications, and the integration of artificial intelligence in operational processes, aiming to advance the company's therapeutic pipeline.

Leadership Team

The Clinical Operations Team at Graviton Bioscience is responsible for overseeing the planning, execution, and management of clinical trials for therapies targeting ROCK2 and other therapeutic compounds. This team ensures that trials are conducted efficiently, compliantly, and in alignment with strategic company goals, thereby facilitating the advancement of Graviton's clinical-stage biotechnology projects.

Graviton Bioscience

Org chart

Teams

Leadership Team

Clinical Operations Team

Offices

Graviton Bioscience

Org chart

Teams

Leadership Team

Clinical Operations Team

Offices

Related companies